Temporal patterns of stromelysin‐1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus

Stromelysin‐1, tissue inhibitor of metalloproteinases‐1 (TIMP‐1), and proteoglycan fragments were quantified in knee synovial fluid samples in a cross‐sectional study of patients who had injury to the anterior cruciate ligament or the meniscus. The average concentrations of stromelysin‐1 and TIMP‐1 increased 25‐fold and 10‐fold within the first day after the trauma, respectively, and the concentration of proteoglycan fragments increased 4‐fold. From approximately 1‐6 months after injury, the levels of these markers were higher after injury to the cruciate ligament than after injury to the meniscus. From 6 months to 18 years after trauma, however, the levels of stromelysin‐1 and TIMP‐1 in patients who had an injury to the ligament were the same as the levels in patients who had a meniscal lesion. but the levels were increased compared with those for a reference group of healthy volunteers. The molar balance of stromelysin‐1 to TIMP‐1 in synovial fluid in both groups of injured joints changed from a balance representing an excess of free inhibitor in the normal joint to one representing an excess of free enzyme in the injured joint. The increased release of these markers to joint fluid both early and late after trauma may be caused by a change in the loading patterns in the knee with an injured ligament or meniscus or by synovitis induced by bleeding. The increased release may be associated with the frequent development of posttraumatic osteoarthritis in patients with these injuries.

[1]  D. Heinegård,et al.  Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. , 1992, Arthritis and rheumatism.

[2]  G. Murphy,et al.  The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. , 1990, Annals of the rheumatic diseases.

[3]  D B Kettelkamp,et al.  Factors effecting late results after meniscectomy. , 1974, The Journal of bone and joint surgery. American volume.

[4]  M. Lark,et al.  Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. , 1990, The Journal of biological chemistry.

[5]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  L. Lohmander,et al.  The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. , 1993, Arthritis and rheumatism.

[7]  N. Bhardwaj,et al.  Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. , 1992, Arthritis and rheumatism.

[8]  L. Lohmander,et al.  The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. , 1992, The Journal of clinical investigation.

[9]  G. Firestein,et al.  Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. , 1991, Arthritis and rheumatism.

[10]  L Ryd,et al.  Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. , 1992, Acta orthopaedica Scandinavica.

[11]  P. Roughley,et al.  Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. , 1989, The Biochemical journal.

[12]  J. Fairclough,et al.  Early osteoarthritis in young sportsmen with severe anterolateral instability of the knee. , 1988, Injury.

[13]  J. Martel-Pelletier,et al.  Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. , 1990, Arthritis and rheumatism.

[14]  L. Lohmander,et al.  Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. , 1993, Arthritis and rheumatism.

[15]  R. Warren,et al.  A clinical and radiographical analysis of 127 anterior cruciate insufficient knees. , 1988, Clinical orthopaedics and related research.

[16]  J. Sandy,et al.  Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. , 1991, The Journal of biological chemistry.

[17]  K. Sommerlath The importance of the meniscus in unstable knees , 1989, The American journal of sports medicine.

[18]  J. Pelletier,et al.  Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. , 1989, The Journal of clinical investigation.

[19]  H. C. Robinson,et al.  Mechanism of catabolism of aggrecan by articular cartilage. , 1992, Archives of biochemistry and biophysics.

[20]  D. W. Jackson,et al.  Occult osseous lesions documented by magnetic resonance imaging associated with anterior cruciate ligament ruptures. , 1991, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[21]  J. Lysholm,et al.  The long-term course after treatment of acute anterior cruciate ligament ruptures , 1991, The American journal of sports medicine.

[22]  A. Ratcliffe,et al.  Increased release of matrix components from articular cartilage in experimental canine osteoarthritis , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  T. Hardingham,et al.  Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. , 1991, The Journal of biological chemistry.

[24]  S. Lohmander,et al.  Markers of cartilage metabolism in arthrosis. A review. , 1991, Acta orthopaedica Scandinavica.

[25]  T. Fairbank Knee joint changes after meniscectomy. , 1948, The Journal of bone and joint surgery. British volume.

[26]  K. Brandt,et al.  Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection. Effect of surgical hemostasis. , 1990, Arthritis and rheumatism.

[27]  S S McCachren,et al.  Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. , 1991, Arthritis and rheumatism.

[28]  F. Noyes,et al.  The symptomatic anterior cruciate-deficient knee. Part I: the long-term functional disability in athletically active individuals. , 1983, The Journal of bone and joint surgery. American volume.

[29]  J. B. McGinity,et al.  Partial or total meniscectomy: a comparative analysis. , 1977, The Journal of bone and joint surgery. American volume.

[30]  E. Thonar,et al.  Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. , 1991, Journal of Rheumatology.

[31]  G. Murphy,et al.  Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. , 1990, Matrix.

[32]  V. Lefebvre,et al.  Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. , 1990, Biochimica et biophysica acta.

[33]  P Kannus,et al.  Conservatively treated tears of the anterior cruciate ligament. Long-term results. , 1987, The Journal of bone and joint surgery. American volume.

[34]  G. R. Dodge,et al.  Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. , 1989, The Journal of clinical investigation.

[35]  D. Eyre,et al.  Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. , 1991, The Journal of biological chemistry.

[36]  L. Ryd,et al.  Increased levels of proteoglycan fragments in knee joint fluid after injury. , 1989, Arthritis and rheumatism.

[37]  J. Case,et al.  Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. , 1989, The American journal of pathology.

[38]  T D Cooke,et al.  Radiographic assessment of progression in osteoarthritis. , 1987, Arthritis and rheumatism.

[39]  M. Lark,et al.  Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. , 1992, The Journal of biological chemistry.

[40]  P. Roughley,et al.  Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. , 1992, The Journal of clinical investigation.

[41]  D. Heinegård,et al.  Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. , 1986, Annals of the rheumatic diseases.

[42]  A. Ladd,et al.  In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. , 1991, Arthritis and rheumatism.